A new clinical implementation study from Vanderbilt University Medical Center measures how physicians have responded to the introduction of routine genetic testing to predict patient response to the commonly prescribed antiplatelet drug clopidogrel.

Vanderbilt’s Asthma, Sinus, and Allergy Program has seen an increase in the number of patients being treated for alpha-gal syndrome, commonly known as the red meat allergy linked to tick bites.

James Powers, M.D., associate professor of Medicine and chief of Geriatric Medicine at the Veteran Affairs Medical Center, was recently named to receive the Iris Award from the Nashville Academy of Nutrition and Dietetics.

A new epidemiological study supports smoking cessation and avoidance of sedentary lifestyle as cancer prevention measures.

Using patients’ health records to assess preparedness for hospital discharge is more effective at predicting readmission or death than commonly used questionnaires.

A new biological therapy, ustekinumab, improves markers of disease activity in patients with severe Crohn’s disease.

Melanoma-specific expression of a certain protein identifies tumors that are more responsive to an immune therapy.